RE:RE:Into reverseThanks Quattro - actually it is supportive to receive independent endorsement as to why we`re here as have otherwise often had to re-read what is being done and the tremendous things that are being and have been achieved or be reminded of them by others on this Board rather than by Management.
Understand that they`re not here to hold our hands and that sometimes news doesn`t arrive as anticipated but there`s a hugely positive sub-text to this story that could be separately deployed as a narrative of the progression of a disruptive technology towards mainstream medicine - to the benefit of the share price and the Company as a whole - by way of scientific news releases unrelated to the waypoints of the Trial. This was actually the Company`s practice until not so long ago. Possibly the OSC forbade this but doubt it.
Anyway Management chose to take the opposite route of a once a Quarter update and then not perform on that either. Sold on the science so not going anywhere but equally certain that this style of Management is highly contributory to where we are. Doubtless suiting someone - just not us.